What is the Share Price of Trident Texofab Ltd?

Trident Texofab Ltd share price is ₹350.55 As on 31 October, 2025|20:45

Home
>
Stocks
>
Trident Texofab Ltd

Trident Texofab Ltd Share Price

Q: What is the Market Cap of Trident Texofab Ltd?

The Market Cap of Trident Texofab Ltd is ₹536 As on 31 October, 2025|20:45

Q: What is PE Ratio of Trident Texofab Ltd?

The P/E ratio of Trident Texofab Ltd is 190 As on 31 October, 2025|20:45

Q: What is PB Ratio of Trident Texofab Ltd?

The PB ratio of Trident Texofab Ltd is 10.07 As on 31 October, 2025|20:45

₹ 0.00 0 (0%)
Updated on 01-01-1970 5:30 AM

Stock Rating

BSE

Pros 2

Cons 7

Trident Texofab Ltd Price Performance

Day's Low
₹0

Day's High
₹0

₹ 0

52-w low
₹0

52-w high
₹0

Day's open
₹0
Previous close
₹0
VWAP
₹0
Lower price band
₹0
Upper price band
₹0

Today's Market Action

Its last traded stock price on BSE was 350.55 down by -2.00%. The total volume of shares on NSE and BSE combined was 9,727 shares. Its total combined turnover was Rs 0.34 crores.

Trident Texofab Ltd Medium and Long Term Market Action

The stock price of Trident Texofab Ltd is down by 0% over the last one month. Don't forget to check the full stock price history in the table below.

Trident Texofab Ltd Fundamentals

Market Cap (Cr): 536
Book Value (₹):
Stock P/E:
Revenue (Cr):
Total Debt (Cr):

Face Value (₹):
Roce (%):
ROE (%):
Earnings (Cr):
Promoter’s Holdings (%):

EPS (₹):
Debt to Equity:
Dividend Yield (%):
Cash (Cr):

Trident Texofab Ltd Mutual fund holdings and trends

FUND NAME	Quantity	Monthly Change (Qty)

Trident Texofab Ltd Shareholding Pattern

Similar Stocks

Company	Price	Market Cap (Cr)	P/E

About Trident Texofab Ltd

Data not available.

Trident Texofab Ltd FAQ's

What is Share Price of Trident Texofab Ltd?

What is the Market Cap of Trident Texofab Ltd?

What is PE Ratio of Trident Texofab Ltd?

What is PB Ratio of Trident Texofab Ltd?

What is the CAGR of Trident Texofab Ltd?

How to Buy Trident Texofab Ltd Share?

Can I buy Trident Texofab Ltd from Samco?

How do I buy Trident Texofab Ltd from Samco?

Financials

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Cash Flow)

Standalone Financial Performace In Graph(Cash Flow)

News

Review

Pros

Strong Working Capital Cycle
The company has a great working capital cycle of 0 days which results in lower investments in working capital and higher asset turnover. This reduces capital requirement of the business and drives RoE and cash flow generation positively. This is extremely positive for long term shareholders of the business.
Above Average Growth Rate
The company is estimated to grow its earnings at a reasonable rate over the next few years which will drive shareholder value creation

Cons

Low Sustainable RoE
The company's sustainable return on equity is lower than the expected cost of capital which implies that the underlying business will destruct value over a period of time due to it's inability to generate superior returns on capital.
Low Return on Capital Employed
The company is unable to generate sufficient return on capital employed which impairs it's ability to generate high return for shareholders after accounting for taxes, interest and other non-equity stakeholders.
Poor Cash Flow Conversion
The business has very poor cash conversion ratio of only 33.33% of operating earnings getting converted into operating cash flow. This implies that increase in profits has not translated into higher cash flows for the business and incrementally higher investments in working capital which works negatively for shareholders.
Low Interest Coverage
The company has a very low Interest coverage ratio of 1.33 times which implies that a large portion of operating profits are getting attributed to payment of interest to debtholders. This leaves lower earnings and cash flows for equity shareholders which is negative for returns.
Highly Cyclical Industry
The company operates an extremely cyclical business with unpredictable earnings and cash flows. This shall result in very high stock price volatility and returns which would negatively impact shareholder returns.
Low Pricing Power & High Competition
The business has extremely low pricing power and is vulnerable to competitive pressure which can significantly impact shareholder returns.
Poor Capital Allocation
The company has disproportionately high amount of assets locked up in working capital, cash and cash equivalents, loans and advances, etc to the extent of 78.22 % of total assets. This reflects poorly on the capital allocation strategy of the management which negatively impacts shareholder returns.

Valuation Analysis

Margin of safety
(31/10/2025)

Margin of Safety Index: High

87.50%

87.50% People are bullish about Trident Texofab Ltd

12.50%

12.50 % People are bearish about Trident Texofab Ltd

What is your opinion about this Stock?

Historical Data

Date	Open	High	Low	Close	Volume	Daily Change %